Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,568 | 3,006 | 3,639 | 3,232 | 2,872 |
| Receivables | 100 | 525 | 581 | 556 | 44 |
| Other current assets | 11 | 27 | 21 | 16 | 11 |
| TOTAL | $5,065 | $4,020 | $4,497 | $4,225 | $3,548 |
| Non-Current Assets | |||||
| Investments And Advances | 5,350 | 5,350 | 5,350 | 5,350 | 5,350 |
| TOTAL | $5,350 | $5,350 | $5,350 | $5,350 | $5,350 |
| Total Assets | $10,415 | $9,370 | $9,847 | $9,575 | $8,898 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 480 | 462 | 483 | 390 | 304 |
| Accrued Expenses | 397 | 338 | 584 | 335 | 396 |
| TOTAL | $877 | $800 | $1,067 | $725 | $700 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $877 | $800 | $1,067 | $725 | $700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,925 | 3,337 | 3,210 | 2,710 | 2,710 |
| Retained earnings | -270,221 | -269,245 | -268,921 | -267,492 | -268,022 |
| TOTAL | $9,538 | $8,570 | $8,780 | $8,850 | $8,198 |
| Total Liabilities And Equity | $10,415 | $9,370 | $9,847 | $9,575 | $8,898 |